Stock Events

Stock Events

PeptiDream 

$6.70
17
+$0.04+0.66%Thursday 18:18

Statistics

Day High
6.8
Day Low
6.8
52W High
12.85
52W Low
5.88
Volume
250
Avg. Volume
432
Mkt Cap
870.42M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Aug 2011
$0.98
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Feb 17Expected
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
-0.06
0.06
0.18
0.29
Expected EPS
0.2925289738
Actual EPS
N/A

Financials

-20.39%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
126.76MRevenue
-25.85MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PPTDF. It's not an investment recommendation.
Mitsubishi UFJ Financial Group
4
8306.TSE
Mitsubishi HC Capital
3
8593.TSE
Microsoft
2
MSFT
Abbvie
2
ABBV

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap20.89B
Alnylam Pharmaceuticals specializes in RNAi therapeutics, competing in the novel drug discovery space similar to PeptiDream's peptide-based discoveries.
Ionis Pharmaceuticals
IONS
Mkt Cap6.55B
Ionis Pharmaceuticals focuses on RNA-targeted drug discovery, presenting competition in the innovative therapeutic area.
CRISPR Therapeutics
CRSP
Mkt Cap4.86B
CRISPR Therapeutics is a leader in gene editing, a cutting-edge area of biotech where PeptiDream could see indirect competition in drug development.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.85B
BioMarin Pharmaceutical focuses on rare disease treatments, overlapping with PeptiDream's interest in novel, hard-to-treat conditions.
Vertex Pharmaceuticals
VRTX
Mkt Cap138.71B
Vertex Pharmaceuticals is known for its work in treating cystic fibrosis and other serious diseases, areas where PeptiDream's technology could also make an impact.
Regeneron Pharmaceuticals
REGN
Mkt Cap93.55B
Regeneron Pharmaceuticals is a biotech company that develops monoclonal antibodies, a direct competitor in the field of biologic drug development.
AMGEN
AMGN
Mkt Cap249.05B
Amgen is a biopharmaceutical giant with a broad portfolio, including innovative therapeutics that could compete with PeptiDream's developments.
Novo Nordisk
NVO
Mkt Cap177.74B
Novo Nordisk is a global healthcare company with a strong focus on diabetes and obesity, areas where PeptiDream's peptide technology could offer novel treatments.

About

PeptiDream Inc. functions as a biopharmaceutical enterprise, concentrating on the identification and progression of therapeutic compounds such as constrained peptides, small molecules, and peptide-drug conjugates. The company's unique product pipeline is underpinned by its proprietary Peptide Discovery Platform System (PDPS), an advanced technology specifically designed for the development of peptide-based drugs. Additionally, PeptiDream maintains an exclusive licensing and collaborative research partnership with Takeda Pharmaceutical Company Limited, aimed at creating peptide drug conjugates for the treatment of neuromuscular conditions. Established in 2006, the company's primary offices are situated in Kawasaki, Japan.
Show More
CEO
Patrick Crawford Reid
Employees
763
Country
Japan
ISIN
JP3836750004

Listings

MX
MX
4587N.MX
OTC Link
US
PPTDF
TSE
JP
4587.TSE

0 Comments

Share your thoughts

FAQs

What is PeptiDream stock price today?▼
The current price of PPTDF is $6.70 USD — it has increased by +0.66% in the past 24 hours. Watch PeptiDream stock price performance more closely on the chart.
What is PeptiDream stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange PeptiDream stocks are traded under the ticker PPTDF.
Is PeptiDream stock price growing?▼
PPTDF stock has fallen by -1.54% compared to the previous week, the month change is a -3.67% fall, over the last year PeptiDream has showed a -34.62% decrease.
What is PeptiDream market cap?▼
Today PeptiDream has the market capitalization of 870.42M
When is the next PeptiDream earnings date?▼
PeptiDream is going to release the next earnings report on February 17, 2027.
What were PeptiDream earnings last quarter?▼
PPTDF earnings for the last quarter are -0.02 USD per share, whereas the estimation was -0.04 USD resulting in a +59.47% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is PeptiDream revenue for the last year?▼
PeptiDream revenue for the last year amounts to 126.76M USD.
What is PeptiDream net income for the last year?▼
PPTDF net income for the last year is -25.85M USD.
Does PeptiDream pay dividends?▼
Yes, PPTDF dividends are paid annual. The last dividend per share was 0.98 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does PeptiDream have?▼
As of November 15, 2026, the company has 763 employees.
In which sector is PeptiDream located?▼
PeptiDream operates in the Health & Wellness sector.
When did PeptiDream complete a stock split?▼
The last stock split for PeptiDream was on June 28, 2017 with a ratio of 2:1.
Where is PeptiDream headquartered?▼
PeptiDream is headquartered in Kawasaki, Japan.